In this interview, Dipak Panigraphy, MD discusses cytokine storms in both COVID-19 and cancer patients, emphasizing their potential to disrupt resolution of inflammation and contribute to unfavorable clinical outcomes. Dr. Panigraphy discusses how standard cancer treatments, including surgery and chemotherapy, may trigger cytokine storms, facilitating the spread of cancer in some patients. Lastly, he discusses his latest research, demonstrating the efficacy of specific specialized pro-resolving mediators (SPMs) molecules in promoting inflammation resolution and preventing treatment-induced metastasis in multiple preclinical cancer models.
Dipak Panigraphy, MD, is an Assistant Professor of Pathology at the Beth Israel Deaconess Medical Center.
From the 17th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, October 2022 in New Orleans, Louisiana
